HCA Healthcare (HCA) analyst forecast and price target
Analyst forecast
Consensus of 29 analyst ratings
Based on 15 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $460.00 from $431.00 | Oct 12, 2026 |
| RBC Capital | Maintained | Outperform | $496.00 from $435.00 | Oct 7, 2026 |
| BMO Capital | Initiated Coverage | Outperform | $495.00 | Sep 23, 2026 |
| Leerink Partners | Maintained | Outperform | $492.00 | Sep 18, 2026 |
| RBC Capital | Maintained | Outperform | $435.00 | Sep 8, 2026 |
| JP Morgan | Maintained | Neutral | $425.00 from $490.00 | Aug 20, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $381.00 from $369.00 | Aug 3, 2026 |
| Mizuho | Maintained | Outperform | $475.00 from $525.00 | Jul 28, 2026 |
| Goldman Sachs | Maintained | Buy | $485.00 from $558.00 | Jul 28, 2026 |
| Barclays | Maintained | Equal-Weight | $387.00 from $402.00 | Jul 27, 2026 |
| Baird | Maintained | Neutral | $393.00 from $396.00 | Jul 27, 2026 |
| Keybanc | Maintained | Overweight | $435.00 from $475.00 | Jul 27, 2026 |
| Oppenheimer | Maintained | Outperform | $485.00 from $520.00 | Jul 27, 2026 |
| Truist Securities | Maintained | Buy | $495.00 from $535.00 | Jul 27, 2026 |
| RBC Capital | Maintained | Outperform | $435.00 | Jul 27, 2026 |
| Morgan Stanley | Maintained | Underweight | $380.00 from $425.00 | Jul 27, 2026 |
| UBS | Maintained | Buy | $579.00 from $635.00 | Jul 27, 2026 |
| Barclays | Maintained | Equal-Weight | $402.00 from $427.00 | Jul 16, 2026 |
| RBC Capital | Maintained | Outperform | $435.00 from $534.00 | Jul 15, 2026 |
| Keybanc | Maintained | Overweight | $475.00 from $510.00 | Jul 14, 2026 |
Frequently asked questions
What is the price target for HCA stock?
The average 12-month analyst price target for HCA Healthcare (HCA) is $457.53, with a high estimate of $579.00 and a low of $380.00, across 15 analysts.
Is HCA a buy, sell, or hold?
Analysts covering HCA Healthcare currently average a Buy rating: 15 buy, 13 hold and 1 sell, from 29 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for HCA?
The average price target of $457.53 implies 2.74% downside from the last price of $470.44.
What is the latest analyst rating on HCA?
On Oct 12, 2026, TD Cowen maintained HCA Healthcare at Buy with a price target of $460.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.